Article Text


Gentamicin serum half-life: a comparison between pregnant and non-pregnant women.
  1. N. Lazebnik,
  2. S. Noy,
  3. R. Lazebnik,
  4. Y. Hezroni,
  5. I. Amoday,
  6. A. Aviram


    The serum half-life of gentamicin following an intravenous dose was compared between 19 pregnant women (28-34 weeks of pregnancy) with premature rupture of the membranes and 17 non-pregnant women with pelvic inflammatory disease, the groups being age and weight matched. A significant reduction of gentamicin half-life was found in the pregnant group.

    Statistics from

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.